NEW YORK (GenomeWeb News) – A University of Texas medical research center will collaborate with GenoLogics to develop an integrated software solution for use in its translational medical bioinformatics research programs, GenoLogics said today.
 
The Vancouver, British Columbia-based company said it will work with the Sealy Center for Molecular Medicine at the University of Texas Medical Branch at Galveston to develop biospecimen-management software.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.